Cystatin C as a Predictor of Mortality and Cardiovascular Events in a Population with Chronic Kidney Disease
Background. We examine whether cystatin C, a surrogate marker of renal function, could identify patients with chronic kidney disease (CKD) with an increased risk of renal disease progression, death, or cardiovascular events. Methods. Data were obtained for 180 patients, with a diagnosis of chronic r...
Saved in:
Main Authors: | Ana Vigil, Emilia Condés, Luis Vigil, Paloma Gallar, Aniana Oliet, Olimpia Ortega, Isabel Rodriguez, Milagros Ortiz, Juan Carlos Herrero, Carmen Mon, Gabriela Cobo, Juana Jimenez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | International Journal of Nephrology |
Online Access: | http://dx.doi.org/10.1155/2014/127943 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
by: Murray B Urowitz, et al.
Published: (2021-04-01) -
Associations of Serum Cystatin C, DNAm Cystatin C, Renal Function, and Mortality in U.S. Adults
by: Yu-Wei Fang, et al.
Published: (2024-12-01) -
Elevation of preoperative cystatin C as an early predictor of contrast-induced nephropathy in patients receiving percutaneous coronary intervention
by: Guoqiang Gu, et al.
Published: (2022-08-01) -
Electrocardiography in Hypertensive Patients without Cardiovascular Events: A Valuable Predictor Tool?
by: J. Ricardo Pires, et al.
Published: (2022-01-01) -
Difference between estimated glomerular filtration rate based on cystatin C versus creatinine and cardiovascular–kidney–metabolic health
by: Xiaoyan Wu, et al.
Published: (2025-01-01)